Skip to main content

Beirne Wealth Consulting Services, LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1697303 SHELTON, CT

Position in LCTX

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$71,100
-$4,050 QoQ
Shares Held
45,000
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Beirne Wealth Consulting Services, LLC holds $1,461,722 across 3 Biotechnology names. LCTX ranks #3 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 LCTX
Lineage Cell Therapeutics, Inc.
This page
45,000 $71,100

All Filings in LCTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $71,100 45,000
2025-12-31 $75,150 45,000
2025-09-30 $76,050 45,000
2025-06-30 $40,950 45,000
2025-03-31 $20,250 45,000
2024-12-31 $22,500 45,000
2024-09-30 $40,950 45,000
2024-06-30 $45,000 45,000
2024-03-31 $66,600 45,000
2023-12-31 $49,050 45,000
2023-09-30 $53,100 45,000
2023-06-30 $63,450 45,000
2023-03-31 $67,500 45,000
2022-12-31 $52,650 45,000
2022-09-30 $50,850 45,000
2022-06-30 $71,100 45,000
2022-03-31 $69,300 45,000
2021-12-31 $110,250 45,000
2021-09-30 $113,400 45,000
2021-06-30 $128,250 45,000
2021-03-31 $105,750 45,000
2020-12-31 $79,200 45,000
2020-09-30 $42,300 45,000
2020-06-30 $60,900 70,000
2020-03-31 $37,350 45,000